tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Scholar Rock Holding Corp (SRRK)
NASDAQ:SRRK
US Market
SRRK
Scholar Rock Holding
RESEARCH TOOLSreports

Scholar Rock Holding (SRRK) Stock News & Sentiment

Compare
532 Followers
Raising Conviction on Scholar Rock: Dual Supply Chain and Broad Apitegromab Adoption Underpin Buy Rating and Higher Target
Premium
Ratings
Raising Conviction on Scholar Rock: Dual Supply Chain and Broad Apitegromab Adoption Underpin Buy Rating and Higher Target
9d ago
SRRK
Scholar Rock: Apitegromab Manufacturing Resolution and Pipeline Expansion Underpin Buy-Rated Risk-Reward Profile
Premium
Ratings
Scholar Rock: Apitegromab Manufacturing Resolution and Pipeline Expansion Underpin Buy-Rated Risk-Reward Profile
22d ago
SRRK
Scholar Rock Details 2026 Strategy and Regulatory Priorities
Premium
Company Announcements
Scholar Rock Details 2026 Strategy and Regulatory Priorities
23d ago
8K
SRRK
Buy/High Risk: Apitegromab’s Differentiated SMA Profile and Expanding Neuromuscular Upside Support Significant Re-Rating Potential
Premium
Ratings
Buy/High Risk: Apitegromab’s Differentiated SMA Profile and Expanding Neuromuscular Upside Support Significant Re-Rating Potential
26d ago
SRRK
Scholar Rock Faces FDA Warning, Plans 2026 Launch
Premium
Company Announcements
Scholar Rock Faces FDA Warning, Plans 2026 Launch
2M ago
8K
SRRK
Scholar Rock’s Earnings Call: Optimism Amid Regulatory Challenges
Premium
Company Announcements
Scholar Rock’s Earnings Call: Optimism Amid Regulatory Challenges
3M ago
SRRK
Buy Rating for Scholar Rock Holdings Driven by Strategic Preparations for Apitegromab’s Market Launch
Premium
Ratings
Buy Rating for Scholar Rock Holdings Driven by Strategic Preparations for Apitegromab’s Market Launch
3M ago
SRRK
More SRRK News >

SRRK News on the Web

Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026
The Motley Fool
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Scholar Rock Holding (SRRK) and Standard BioTools (LAB)
TipRanks News
Bullish
Bank of America Securities Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)
TipRanks News
Bullish
SRRK: HC Wainwright Raises Price Target to $58, Maintains Buy Rating | SRRK Stock News
GuruFocus News
Bullish
Raising Conviction on Scholar Rock: Dual Supply Chain and Broad Apitegromab Adoption Underpin Buy Rating and Higher Target
TipRanks News
Bullish
Scholar Rock price target raised to $58 from $44 at H.C. Wainwright
TipRanks News
Bullish
Insider Sell: Mo Qatanani Sells Shares of Scholar Rock Holding Corp (SRRK)
GuruFocus News
Bearish
Wedbush Remains a Buy on Scholar Rock Holding (SRRK)
TipRanks News
Bullish

News Score - Last 7 Days

Positive
SRRK
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SRRK’s Media Buzz Sentiment?
2 articles about SRRK were published this week. In an average week, 3.5 articles are published.
    What is SRRK’s weekly average amount of articles?
    In an average week, 3.5 articles about SRRK are published.
      What is SRRK’s News Sentiment?
      100% of articles about SRRK were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        DVADaVita
        QNCXQuince Therapeutics
        RMDResmed
        PLXProtalix
        LONNLonza Group Ltd
        Showing the stocks with the most bullish news sentiment over the past week